 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 3 | 1/1 | 返回列表 |
| 查看: 468 | 回復(fù): 2 | |||
lijizhi79木蟲 (小有名氣)
|
[交流]
GlaxoSmithKline and Novartis, starring players in a Big Pharma deal bonanza 已有2人參與
|
|
While the chattering classes were chattering about a potential Pfizer-AstraZeneca merger yesterday, three other drug giants were putting the finishing touches on a big announcement. Novartis ($NVS), whose strategic review has been making headlines for almost a year, agreed to swap some assets with GlaxoSmithKline ($GSK) and sell its animal health business to Eli Lilly ($LLY). Altogether, the transactions are worth more than $25 billion, a decent-sized figure in the scheme of pharma M&A. Even bigger? The changes these deals will wreak at the three companies, Novartis and GSK in particular. Glaxo will be out of the cancer business. Novartis will be out of vaccines and animal health. Together, the two companies will run a consumer health joint venture with a combined $11 billion or so in sales. And Eli Lilly will have an even heftier presence in animal health, where its Elanco unit already boasts major market share. We've taken a look at the different pieces of the three-way deal frenzy in Tuesday's news coverage. Follow the links to find out more. But here are the basics: Why did Glaxo choose to get out of the cancer business, and what does Novartis get for its $16 billion? CEOs Andrew Witty and Joe Jimenez have something to say about that. What does GSK propose to do with Novartis' vaccines business, particularly its meningitis B shot Bexsero? Build scale and add sales in a business that relies on high volumes--advantages worth up to $7.1 billion in up-front and milestone payments. How will Glaxo and Novartis meld their consumer health line-ups and save money in the process? In a joint venture controlled by GSK, with well-known brand names and distribution all over the world. What will Lilly gain in picking up Novartis' animal health business for $5.4 billion? Status as the second-biggest animal health company worldwide, plus a boost to this year's top line, for starters. We have one unanswered question, though. With rumors about Novartis' strategic review swirling for months, an asset swap with GSK never came up. How did these companies keep it quiet? -- Tracy Staton |
回復(fù)此樓» 猜你喜歡
WoS一區(qū)Frontiers in Genome Editing基因編輯方法與應(yīng)用方向?qū)ｎ}邀稿（影響因子4.9）
已經(jīng)有0人回復(fù)
-
WoS一區(qū)Frontiers in Genome Editing基因編輯方法與應(yīng)用方向?qū)ｎ}邀稿（影響因子4.9）
已經(jīng)有0人回復(fù)
-
藥理學(xué)論文潤色/翻譯怎么收費?
已經(jīng)有286人回復(fù)
-
WoS一區(qū)Frontiers in Genome Editing基因編輯方法與應(yīng)用方向?qū)ｎ}邀稿（影響因子4.9）
已經(jīng)有0人回復(fù)
-
WoS一區(qū)Frontiers in Genome Editing基因編輯方法與應(yīng)用方向?qū)ｎ}邀稿（影響因子4.9）
已經(jīng)有0人回復(fù)
-
跪求一支AAV293細胞
已經(jīng)有1人回復(fù)
-
廣西醫(yī)科大學(xué)基礎(chǔ)醫(yī)學(xué)院自身免疫病課題組招收基礎(chǔ)醫(yī)學(xué)、藥學(xué)和生物學(xué)等專業(yè)的研究生
已經(jīng)有7人回復(fù)
-
[學(xué)習(xí)資料分享] FAERS數(shù)據(jù)庫的不良反應(yīng)挖掘(頻數(shù)法/貝葉斯法)
已經(jīng)有1人回復(fù)
-
招收醫(yī)學(xué)、基礎(chǔ)醫(yī)學(xué)類調(diào)劑研究生
已經(jīng)有0人回復(fù)
-
是否屬于脾腎陽虛證
已經(jīng)有0人回復(fù)
-
廣西醫(yī)科大學(xué)基礎(chǔ)醫(yī)學(xué)院自身免疫病課題組招收基礎(chǔ)醫(yī)學(xué)相關(guān)專業(yè)的調(diào)劑研究生
已經(jīng)有2人回復(fù)
for5
木蟲 (正式寫手)
- 應(yīng)助: 127 (高中生)
- 金幣: 3356.6
- 紅花: 10
- 帖子: 880
- 在線: 283.6小時
- 蟲號: 696070
- 注冊: 2009-02-04
- 性別: GG
- 專業(yè): 微生物生理與生物化學(xué)
2樓2014-04-23 10:56:01
3樓2014-04-23 11:49:54
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 lijizhi79 的主題更新
| 3 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿天津大學(xué)化學(xué)工藝專業(yè)（081702）315分求調(diào)劑 +11 | yangfz 2026-03-17 | 11/550 |
|
|---|---|---|---|---|
|
[考研] 求調(diào)劑，一志愿:南京航空航天大學(xué)大學(xué) ，080500材料科學(xué)與工程學(xué)碩，總分289分 +3 | @taotao 2026-03-19 | 3/150 |
|
|
|
[考研] 281求調(diào)劑（0805） +9 | 煙汐憶海 2026-03-16 | 19/950 |
|
|
|
[考研] 274求調(diào)劑 +6 | S.H1 2026-03-18 | 6/300 |
|
|
|
[考研] 本科鄭州大學(xué)物理學(xué)院，一志愿華科070200學(xué)碩，346求調(diào)劑 +4 | 我不是一根蔥 2026-03-18 | 4/200 |
|
|
|
[考研] 295求調(diào)劑 +3 | 一志愿京區(qū)211 2026-03-18 | 5/250 |
|
|
|
[考研] 化學(xué)工程321分求調(diào)劑 +15 | 大米飯！ 2026-03-15 | 18/900 |
|
|
|
[考研] 312求調(diào)劑 +8 | 陌宸希 2026-03-16 | 9/450 |
|
|
|
[考研] 303求調(diào)劑 +4 | 睿08 2026-03-17 | 6/300 |
|
|
|
[考研] 環(huán)境工程調(diào)劑 +8 | 大可digkids 2026-03-16 | 8/400 |
|
|
|
[考研] 278求調(diào)劑 +5 | 煙火先于春 2026-03-17 | 5/250 |
|
|
|
[考研] 332求調(diào)劑 +6 | Zz版 2026-03-13 | 6/300 |
|
|
|
[考研] 材料工程專碩274一志愿211求調(diào)劑 +6 | 薛云鵬 2026-03-15 | 6/300 |
|
|
|
[考研] 東南大學(xué)364求調(diào)劑 +5 | JasonYuiui 2026-03-15 | 5/250 |
|
|
|
[考研] 機械專碩325，尋找調(diào)劑院校 +3 | y9999 2026-03-15 | 5/250 |
|
|
|
[考研] 085600材料與化工 求調(diào)劑 +13 | enenenhui 2026-03-13 | 14/700 |
|
|
|
[考研] 326求調(diào)劑 +3 | mlpqaz03 2026-03-15 | 3/150 |
|
|
|
[考研] 中科大材料與化工319求調(diào)劑 +3 | 孟鑫材料 2026-03-14 | 3/150 |
|
|
|
[考研] 招收0805（材料）調(diào)劑 +3 | 18595523086 2026-03-13 | 3/150 |
|
|
|
[考研] 321求調(diào)劑（食品/專碩） +3 | mxcz321 2026-03-12 | 6/300 |
|